Latest Market Growth News

Navigator Global Investments reports a 3% rise in total assets under management to USD 87 billion, driven by strong growth in Lighthouse Partners and private markets despite a challenging investment landscape.

Southern Cross Media Group reports a robust Q1 FY26 with audio revenues rising 4.7% and EBITDA more than doubling, while preparing for a pivotal merger review.

Orthocell has reported a record $3 million revenue for the September quarter, driven by strong sales of its nerve repair product Remplir™ in Australia and Singapore, with early US sales and Canadian market entry poised to accelerate growth.

First Graphene’s PureGRAPH technology underpins a new solar thermal product range launched in the UK by Senergy Innovations, targeting significant energy savings and market growth ahead of the 2027 Future Homes Standard.

Locksley Resources has completed its second tranche placement with Tribeca, significantly strengthening its cash reserves to support its U.S. mine-to-market ambitions.

The Calmer Co. has secured $700,000 in the first tranche of a $1.4 million convertible note raise, welcoming US distributor Applied Food Sciences as a strategic investor to fuel its expanding wholesale presence.

Memphasys Limited is intensifying its commercial push for Felix, an innovative automated sperm separation system for IVF, backed by a landmark Middle East partnership and a fresh capital raise to scale manufacturing and sales.

Livium’s Envirostream has extended its battery recycling contract with LG Energy Solution to 2029, expanding its scope to include end-of-life residential lithium-ion batteries across Australia.

Adherium Limited’s iCARE study reports unprecedented medication adherence improvements and sustained patient engagement in COPD and asthma care, highlighting significant clinical and economic benefits.

An independent study confirms Condor Energy’s Piedra Redonda gas field offshore Peru offers multiple viable pathways to early monetisation and long-term growth, positioning it as a strategic regional energy asset.

Metal Powder Works Limited has completed a A$15 million institutional placement, strengthening its balance sheet to scale production and expand its market presence.

Botanix Pharmaceuticals’ ECCLOCK® gel, a treatment for excessive sweating, has secured regulatory approval in South Korea, paving the way for a commercial launch in early 2026.